|
Re: Resverlogix Announces Change in Fiscal Year-End to December 31
|
4
|
Resverlogix Corp.
|
Mar 14, 2021 11:24PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
9
|
Resverlogix Corp.
|
Oct 14, 2020 10:30PM
|
|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
4
|
Resverlogix Corp.
|
Jun 16, 2018 01:37AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 13, 2023 11:58AM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
3
|
Resverlogix Corp.
|
Jun 14, 2023 09:18AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 10:32AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
6
|
Resverlogix Corp.
|
Mar 11, 2019 10:54PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
5
|
Resverlogix Corp.
|
Mar 12, 2019 01:22PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
4
|
Resverlogix Corp.
|
Mar 11, 2019 09:29AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
5
|
Resverlogix Corp.
|
Mar 11, 2019 09:38AM
|
|
Re: Resverlogix Announces Proposed Offering of Units
|
2
|
Resverlogix Corp.
|
May 14, 2019 08:31PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 01:09PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Apr 01, 2020 04:15PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 11:45PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 03:42PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
4
|
Resverlogix Corp.
|
Mar 31, 2020 04:38PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 06:34PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
2
|
Resverlogix Corp.
|
Mar 31, 2020 08:01PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Atherosclerosis Journal
|
3
|
Resverlogix Corp.
|
Nov 28, 2018 09:42AM
|
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
5
|
Resverlogix Corp.
|
Apr 11, 2018 07:59AM
|
